| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 2.76e-06 | 748 | 19 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 4.26e-06 | 35 | 19 | 3 | GO:0008045 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 4.38e-06 | 802 | 19 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 5.03e-06 | 819 | 19 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 5.32e-06 | 826 | 19 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | axonogenesis | 8.32e-06 | 566 | 19 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | axon development | 1.70e-05 | 642 | 19 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 5.82e-05 | 1194 | 19 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | neuron projection development | 9.29e-05 | 1285 | 19 | 7 | GO:0031175 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.17e-04 | 285 | 19 | 4 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.19e-04 | 286 | 19 | 4 | GO:0097485 | |
| GeneOntologyBiologicalProcess | neuron development | 2.10e-04 | 1463 | 19 | 7 | GO:0048666 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 6.45e-04 | 41 | 19 | 2 | GO:0035025 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 6.89e-04 | 192 | 19 | 3 | GO:0050770 | |
| GeneOntologyBiologicalProcess | placenta development | 7.43e-04 | 197 | 19 | 3 | GO:0001890 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.04e-03 | 52 | 19 | 2 | GO:0071526 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 6.74e-05 | 13 | 20 | 2 | GO:0002116 | |
| MousePheno | abnormal interdigital cell death | 1.39e-05 | 5 | 17 | 2 | MP:0009874 | |
| Domain | Growth_fac_rcpt_ | 1.65e-05 | 156 | 19 | 4 | IPR009030 | |
| Domain | Furin_repeat | 1.49e-04 | 18 | 19 | 2 | IPR006212 | |
| Domain | FU | 1.49e-04 | 18 | 19 | 2 | SM00261 | |
| Domain | cEGF | 3.14e-04 | 26 | 19 | 2 | IPR026823 | |
| Domain | cEGF | 3.14e-04 | 26 | 19 | 2 | PF12662 | |
| Domain | - | 9.59e-04 | 449 | 19 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.04e-03 | 459 | 19 | 4 | IPR013083 | |
| Domain | EGF | 1.64e-03 | 235 | 19 | 3 | SM00181 | |
| Domain | EGF-like_dom | 1.94e-03 | 249 | 19 | 3 | IPR000742 | |
| Domain | Zinc_finger_PHD-type_CS | 1.96e-03 | 65 | 19 | 2 | IPR019786 | |
| Domain | PHD | 2.60e-03 | 75 | 19 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 2.88e-03 | 79 | 19 | 2 | IPR019787 | |
| Domain | ZF_BBOX | 2.96e-03 | 80 | 19 | 2 | PS50119 | |
| Domain | ZF_RING_1 | 3.01e-03 | 291 | 19 | 3 | PS00518 | |
| Domain | Znf_B-box | 3.03e-03 | 81 | 19 | 2 | IPR000315 | |
| Domain | ZF_RING_2 | 3.22e-03 | 298 | 19 | 3 | PS50089 | |
| Domain | EGF_CA | 3.41e-03 | 86 | 19 | 2 | PF07645 | |
| Domain | RING | 3.44e-03 | 305 | 19 | 3 | SM00184 | |
| Domain | PHD | 3.64e-03 | 89 | 19 | 2 | SM00249 | |
| Domain | Znf_PHD | 3.80e-03 | 91 | 19 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.14e-03 | 95 | 19 | 2 | PS50016 | |
| Domain | Znf_RING | 4.15e-03 | 326 | 19 | 3 | IPR001841 | |
| Domain | ZF_PHD_1 | 4.22e-03 | 96 | 19 | 2 | PS01359 | |
| Domain | EGF_Ca-bd_CS | 4.31e-03 | 97 | 19 | 2 | IPR018097 | |
| Domain | EGF_CA | 4.48e-03 | 99 | 19 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.57e-03 | 100 | 19 | 2 | PS00010 | |
| Domain | Ig_E-set | 4.94e-03 | 104 | 19 | 2 | IPR014756 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.12e-03 | 106 | 19 | 2 | IPR000152 | |
| Domain | EGF_CA | 6.73e-03 | 122 | 19 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.94e-03 | 124 | 19 | 2 | IPR001881 | |
| Domain | Znf_FYVE_PHD | 9.64e-03 | 147 | 19 | 2 | IPR011011 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 6.60e-05 | 11 | 16 | 2 | MM15046 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.26e-04 | 15 | 16 | 2 | MM15037 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.27e-04 | 20 | 16 | 2 | M18415 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 3.29e-04 | 24 | 16 | 2 | M2243 | |
| Pubmed | ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. | 3.14e-07 | 2 | 20 | 2 | 22378040 | |
| Pubmed | Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. | 3.14e-07 | 2 | 20 | 2 | 15210733 | |
| Pubmed | ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. | 1.88e-06 | 4 | 20 | 2 | 18025083 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 20558745 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 3.01e-06 | 1201 | 20 | 7 | 35696571 | |
| Pubmed | Suppression of bone formation by osteoclastic expression of semaphorin 4D. | 6.59e-06 | 7 | 20 | 2 | 22019888 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 20011118 | ||
| Pubmed | 1.61e-05 | 86 | 20 | 3 | 37253089 | ||
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 25315821 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.68e-05 | 1105 | 20 | 6 | 35748872 | |
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 3.28e-05 | 15 | 20 | 2 | 31285543 | |
| Pubmed | 6.24e-05 | 1285 | 20 | 6 | 35914814 | ||
| Pubmed | Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney. | 7.89e-05 | 23 | 20 | 2 | 21035938 | |
| Pubmed | 7.89e-05 | 23 | 20 | 2 | 12955145 | ||
| Pubmed | 9.54e-05 | 156 | 20 | 3 | 37108203 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.41e-04 | 1489 | 20 | 6 | 28611215 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.59e-04 | 219 | 20 | 3 | 31353912 | |
| Pubmed | 2.93e-04 | 44 | 20 | 2 | 26471122 | ||
| Pubmed | 3.56e-04 | 244 | 20 | 3 | 29884807 | ||
| Pubmed | 4.62e-04 | 650 | 20 | 4 | 38777146 | ||
| Pubmed | 5.09e-04 | 58 | 20 | 2 | 23284291 | ||
| GeneFamily | PHD finger proteins | 1.57e-03 | 90 | 12 | 2 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.95e-03 | 394 | 12 | 3 | 471 | |
| GeneFamily | Ring finger proteins | 1.38e-02 | 275 | 12 | 2 | 58 | |
| Coexpression | GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP | 3.39e-07 | 199 | 20 | 5 | M8164 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.67e-06 | 198 | 20 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.55e-05 | 157 | 20 | 3 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 189 | 20 | 3 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.27e-05 | 192 | 20 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.40e-05 | 193 | 20 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.06e-05 | 198 | 20 | 3 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.06e-05 | 198 | 20 | 3 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.19e-05 | 199 | 20 | 3 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.19e-05 | 199 | 20 | 3 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.19e-05 | 199 | 20 | 3 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 3124_UP | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.32e-05 | 196 | 20 | 4 | 3896_UP | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 2.32e-05 | 196 | 20 | 4 | 4372_UP | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.05e-03 | 71 | 20 | 2 | DOID:0050700 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DCLACLHFNHSGICE | 251 | P04626 | |
| LVECQECHNLYHRDC | 176 | Q96CB8 | |
| CADCHHLCQHCAADL | 806 | Q86XX4 | |
| DLCLLTHQGHVNCSC | 2491 | Q07954 | |
| HSFCKNCLERCLDHA | 496 | Q17RB8 | |
| SCAQHLDCASCLAHR | 481 | O43157 | |
| HLHCFACIICNRQLA | 111 | Q969G2 | |
| HCLNEILDLCHSFCS | 581 | Q9UGJ1 | |
| DLDRCCLSHHCCLEQ | 341 | Q02509 | |
| DICKHHANLCLNGRC | 496 | P35556 | |
| NCNNCCNNLHHDIER | 321 | Q9Y4I5 | |
| CDTCRQLHAAHCAAL | 371 | Q8IUW3 | |
| AIQLDCSHIFHLQCC | 4441 | O75592 | |
| SLEDCHCNLFCLADL | 11 | Q9UHV7 | |
| LTEHCHQLVDQCCNA | 226 | Q9BR01 | |
| CSLCDNCVERFDHHC | 181 | Q8IZN3 | |
| MHNLCCDNCHSHVAL | 136 | Q9H0R3 | |
| HLCSLCNVECSHLKD | 426 | Q14966 | |
| NQCEFCFHLDCHLPA | 641 | Q13263 | |
| CLACDNHALQEAHLC | 596 | P23276 |